Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma

Glioblastoma (GBM) is the most aggressive adult glioma with a median survival of 14 months. While standard treatments (safe maximal resection, radiation, and temozolomide chemotherapy) have increased the median survival in favorable O(6)-methylguanine-DNA methyltransferase (MGMT)-methylated GBM (~21...

Descripción completa

Detalles Bibliográficos
Autores principales: McKelvey, Kelly J., Wilson, Erica B., Short, Susan, Melcher, Alan A., Biggs, Michael, Diakos, Connie I., Howell, Viive M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039392/
https://www.ncbi.nlm.nih.gov/pubmed/33854970
http://dx.doi.org/10.3389/fonc.2021.633210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039392/
https://www.ncbi.nlm.nih.gov/pubmed/33854970
http://dx.doi.org/10.3389/fonc.2021.633210

Ejemplares similares